New light and drug combo targets rosacea redness
NCT ID NCT07343635
Summary
This study aims to see if a combination treatment is effective and safe for controlling a common skin condition called rosacea. It will test a specific light therapy and two medications (tofacitinib and doxycycline) in 186 Chinese adults with mild to moderate facial redness and visible blood vessels. The main goal is to see how many participants have clear or almost clear skin after 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMATOTELANGIECTATIC ROSACEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.